Curie Capital

Curie Capital operates as a specialized venture capital firm focused on life sciences, providing seed and Series A funding to innovative early-stage companies. It targets biotechnology, pharmaceuticals, and medical technology, supporting therapeutics, diagnostics, and advanced medical devices. Beyond capital, the firm offers experience, a robust network, and strategic guidance through research and development.

Established in Amsterdam in 2018, Curie Capital was founded by Mariette van der Velden and Han de Groot. Their backgrounds in life sciences investment and entrepreneurship provided the insight to create a firm actively identifying and nurturing scientific breakthroughs. This enables them to support nascent companies in transforming innovations into tangible medical products.

Curie Capital primarily invests in early-stage Dutch companies developing novel medicines and advanced medical technologies. Its central vision is to empower these enterprises, assisting them through development cycles to bring impactful innovations to patients. The firm is dedicated to fostering a sustainable future within the life sciences industry.